Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Cholankeril

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
Hepatology (Baltimore, Md.)|October 1, 2016
Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fastMuhammad Ali Khan, George Cholankeril, Colin W Howden
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 30, 2023
Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021Donghee Kim, Richie Manikat, George Cholankeril, et al.
Journal of General Internal Medicine|March 6, 2021
Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2026
MetALD in Women: Epidemiology, Natural History, and Clinical OutcomesSomaya Albhaisi, George Cholankeril, Fasiha Kanwal, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Optimal timing for hepatitis C antiviral therapy in the peritransplant period?George Cholankeril, Robert J Wong, Donghee Kim, et al.
European Journal of Nutrition|January 23, 2024
Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscanDonghee Kim, Brandon J Perumpail, George Cholankeril, et al.
Journal of Hepatology|July 22, 2024
Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints"George Cholankeril, Jennifer R Kramer, Xian Yu, et al.
World Journal of Hepatology|May 5, 2017
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementGeorge Cholankeril, Ronak Patel, Sandeep Khurana, et al.
The American Journal of Gastroenterology|November 6, 2020
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?Branden Tarlow, John Gubatan, Muhammad Ali Khan, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|October 1, 2016
Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fastMuhammad Ali Khan, George Cholankeril, Colin W Howden
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 30, 2023
Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021Donghee Kim, Richie Manikat, George Cholankeril, et al.
Journal of General Internal Medicine|March 6, 2021
Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2026
MetALD in Women: Epidemiology, Natural History, and Clinical OutcomesSomaya Albhaisi, George Cholankeril, Fasiha Kanwal, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Optimal timing for hepatitis C antiviral therapy in the peritransplant period?George Cholankeril, Robert J Wong, Donghee Kim, et al.
European Journal of Nutrition|January 23, 2024
Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscanDonghee Kim, Brandon J Perumpail, George Cholankeril, et al.
Journal of Hepatology|July 22, 2024
Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints"George Cholankeril, Jennifer R Kramer, Xian Yu, et al.
World Journal of Hepatology|May 5, 2017
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementGeorge Cholankeril, Ronak Patel, Sandeep Khurana, et al.
The American Journal of Gastroenterology|November 6, 2020
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?Branden Tarlow, John Gubatan, Muhammad Ali Khan, et al.
Pageof 20